Literature DB >> 8401181

Potential sites of infection that develop in febrile neutropenic patients.

I R Nováková1, J P Donnelly, B De Pauw.   

Abstract

Three hundred episodes of neutropenia were reviewed for the occurrence of potential sites of infection. Ninety sites (30 per cent) were identified at the onset of fever independent of initial bacteraemia which was encountered in 104 episodes (35%) and predominantly involved Gram-positive cocci. A further 90 sites were recorded involving mainly the lower respiratory tract (58%) and skin and soft tissue (18%). These changes evolved significantly later (mean of 5.1 and 4.3 days respectively) than did other foci which mainly presented at the onset of fever (p < 0.01). However the infectious aetiology was established in only 54 cases overall with fungi being responsible for 25 of 45 cases of lower respiratory tract infections with a known microbiological aetiology. The mortality associated with initial bacteraemia, focus at onset and unexplained fever was 11-14% while that associated with the development of a subsequent focus was 28% with lung infiltrates carrying the worst prognosis. Therefore rather than being seen as a final solution for possible infectious complications, empiric therapy provides an opportunity for daily review of the patient thereby increasing the likelihood of both explaining initial fever and diagnosing subsequent infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401181     DOI: 10.3109/10428199309148203

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Infections in neutropenic patients. II: Management.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

2.  Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.

Authors:  H Link; G Maschmeyer; P Meyer; W Hiddemann; W Stille; M Helmerking; D Adam
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

3.  Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.

Authors:  Emilia Hardak; Irit Avivi; Lina Berkun; Ayelet Raz-Pasteur; Noa Lavi; Yuval Geffen; Mordechai Yigla; Ilana Oren
Journal:  Infection       Date:  2016-01-20       Impact factor: 3.553

4.  Skin and soft tissue infections in patients with solid tumours.

Authors:  Diamantis P Kofteridis; Antonios Valachis; Eirini Koutsounaki; Sofia Maraki; Eleni Mavrogeni; Foteini N Economidou; Dimitra Dimopoulou; Kostas Kalbakis; Vassilis Georgoulias; George Samonis
Journal:  ScientificWorldJournal       Date:  2012-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.